Mepolizumab failed to affect bullous pemphigoid: a randomized, placebo-controlled, double-blind phase 2 pilot study.

Simon, Dagmar; Yousefi, Shida; Cazzaniga, Simone; Bürgler, Christina; Radonjic, Susanne; Houriet, Carine; Heidemeyer, Kristine; Klötgen, Hans-Willhelm; Kozlowski, Evelyne; Borradori, Luca; Simon, Hans-Uwe (2019). Mepolizumab failed to affect bullous pemphigoid: a randomized, placebo-controlled, double-blind phase 2 pilot study. (In Press). Allergy Wiley 10.1111/all.13950

[img] Text
Simon_et_al-2019-Allergy.pdf - Accepted Version
Restricted to registered users only until 23 June 2020.
Available under License Publisher holds Copyright.

Download (322kB) | Request a copy

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Dermatology
04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Pharmacology

UniBE Contributor:

Simon, Dagmar; Yousefi, Shida; Cazzaniga, Simone; Bürgler, Christina; Radonjic, Susanne Irene; Houriet, Carine; Heidemeyer, Kristine; Klötgen, Hans-Willhelm; Kozlowski, Eveline; Borradori, Luca and Simon, Hans-Uwe

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1398-9995

Publisher:

Wiley

Language:

English

Submitter:

Sabrina Cookman

Date Deposited:

07 Aug 2019 07:47

Last Modified:

23 Oct 2019 01:23

Publisher DOI:

10.1111/all.13950

PubMed ID:

31230371

BORIS DOI:

10.7892/boris.132368

URI:

https://boris.unibe.ch/id/eprint/132368

Actions (login required)

Edit item Edit item
Provide Feedback